By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Lejrvej 37-41

Værløse    DK-3500  Denmark
Phone: 45-44-47-80-80 Fax: 45-44-47-24-25



Company News
Egalet Deploys Salesforce To Begin Educating Healthcare Providers About ARYMO ER 3/30/2017 9:32:43 AM
Egalet Announces FDA Does Not Object To Egalet's Distribution Of Materials And Communications To Healthcare Professionals Regarding Abuse-Deterrent Properties Of ARYMO ER Via Intranasal Route 3/29/2017 8:22:31 AM
Egalet Announces Issuance Of New U.S. And International Patents For Guardian Technology 3/23/2017 8:39:31 AM
Egalet Reports Fourth Quarter And Full Year 2016 Financial Results 3/9/2017 11:00:09 AM
Egalet Release: Company Closes Second Tranche Of $80 Million Secured Debt Financing 1/19/2017 8:12:39 AM
Egalet Release: Drug Company Receives FDA Approval For ARYMO ER (Morphine Sulfate) C-II, An Extended-Release Morphine Product Formulated With Abuse-Deterrent Properties For Treatment Of Chronic Pain 1/10/2017 5:53:18 AM
Egalet Announces Positive Top-Line Results From An Intranasal Human Abuse Potential Study Of Egalet-002 12/16/2016 10:43:37 AM
Egalet Appoints Robert Roche To Board Of Directors 12/8/2016 8:51:25 AM
Egalet Announces Issuance Of New Patent For Egalet-002 And Guardian Technology 12/6/2016 8:13:48 AM
Egalet Announces Filing Of Supplemental New Drug Application For OXAYDO To FDA 12/2/2016 6:20:55 AM